Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 1
2012 1
2016 1
2017 1
2018 1
2019 2
2020 2
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Effects of aging on angiogenesis.
Lähteenvuo J, Rosenzweig A. Lähteenvuo J, et al. Circ Res. 2012 Apr 27;110(9):1252-64. doi: 10.1161/CIRCRESAHA.111.246116. Circ Res. 2012. PMID: 22539758 Free PMC article. Review.
Advances and Challenges in Cardiovascular Gene Therapy.
Lähteenvuo J, Ylä-Herttuala S. Lähteenvuo J, et al. Hum Gene Ther. 2017 Nov;28(11):1024-1032. doi: 10.1089/hum.2017.129. Epub 2017 Aug 15. Hum Gene Ther. 2017. PMID: 28810808 Review.
Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia.
Pajula J, Lähteenvuo J, Lähteenvuo M, Honkonen K, Halonen P, Hätinen OP, Kuivanen A, Heikkilä M, Nurro J, Hartikainen J, Ylä-Herttuala S. Pajula J, et al. Among authors: lahteenvuo j. Front Bioeng Biotechnol. 2022 Dec 22;10:999226. doi: 10.3389/fbioe.2022.999226. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36619378 Free PMC article.
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease.
Delgado J, Voltz C, Stain M, Lapveteläinen T, Urach S, Lähteenvuo J, Penttilä K, Gisselbrecht C, Enzmann H, Pignatti F. Delgado J, et al. Among authors: lahteenvuo j. Hemasphere. 2021 Jun 28;5(7):e604. doi: 10.1097/HS9.0000000000000604. eCollection 2021 Jul. Hemasphere. 2021. PMID: 34235401 Free PMC article. Review.
Susceptibility to Cardiac Arrhythmias and Sympathetic Nerve Growth in VEGF-B Overexpressing Myocardium.
Lähteenvuo J, Hätinen OP, Kuivanen A, Huusko J, Paananen J, Lähteenvuo M, Nurro J, Hedman M, Hartikainen J, Laham-Karam N, Mäkinen P, Räsänen M, Alitalo K, Rosenzweig A, Ylä-Herttuala S. Lähteenvuo J, et al. Mol Ther. 2020 Jul 8;28(7):1731-1740. doi: 10.1016/j.ymthe.2020.03.011. Epub 2020 Mar 19. Mol Ther. 2020. PMID: 32243833 Free PMC article.
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma.
Tzogani K, Penttilä K, Lähteenvuo J, Lapveteläinen T, Lopez Anglada L, Prieto C, Garcia-Ochoa B, Enzmann H, Gisselbrecht C, Delgado J, Pignatti F. Tzogani K, et al. Among authors: lahteenvuo j. Oncologist. 2021 Jan;26(1):70-76. doi: 10.1002/onco.13592. Epub 2020 Nov 23. Oncologist. 2021. PMID: 33179377 Free PMC article. Clinical Trial.
Growth factor therapy and autologous lymph node transfer in lymphedema.
Lähteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lähteenvuo J, Kholová I, Alitalo K, Ylä-Herttuala S, Saaristo A. Lähteenvuo M, et al. Among authors: lahteenvuo j. Circulation. 2011 Feb 15;123(6):613-20. doi: 10.1161/CIRCULATIONAHA.110.965384. Epub 2011 Jan 31. Circulation. 2011. PMID: 21282502
13 results